Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Teladoc Health (TDOC) shares came under focus after the company reported second quarter 2026 results, which showed lower sales and a wider net loss, alongside fresh revenue and earnings guidance for the rest of the year.
See our latest analysis for Teladoc Health.
The earnings release and updated guidance appear to be weighing heavily on sentiment. Teladoc Health's share price return is down 28.32% over the past day and 24.02% over the past week, while the 1-year total shareholder return has fallen 8.74% and the 5-year total shareholder return is down 95.70%. This points to weak long term performance despite a slightly positive 90 day share price return of 1.86%.
If Teladoc Health's recent swing has you reassessing opportunities in digital care, it may help to widen your lens using a curated list of healthcare focused AI stocks such as 41 healthcare AI stocks
Teladoc Health now trades at a steep discount to one valuation estimate and sits below the average analyst price target, yet the business still reports falling quarterly sales and a net loss. Is the market being cautious, or simply realistic about the risks?
Most Popular Narrative: 56.1% Undervalued
Based on one widely followed narrative, Teladoc Health's fair value of $15.00 sits well above the last close at $6.58, which frames the current slide in a very different light.
This creates a high-margin-of-safety value play where any modest operational recovery triggers significant upside re-rating.
| Fair Value | $12.00 to $15.00 | * Insurance Pivot Succeeds: BetterHelp insurance revenue ramps ($90M+ ARR); FCF hits $150M+.
Curious what sits behind that $15.00 fair value for Teladoc Health. The narrative leans heavily on free cash flow durability, the BetterHelp insurance shift and a richer earnings multiple that the market is currently ignoring.
Result: Fair Value of $15.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Teladoc Health still faces pressure if the BetterHelp insurance pivot underdelivers or if telehealth competitors gain share faster than its virtual care platform can adjust.
Find out about the key risks to this Teladoc Health narrative.
Next Steps
With sentiment clearly mixed around Teladoc Health, it makes sense to look past the headlines and weigh the risks and rewards for yourself. To balance the concerns with the potential upside, take a closer look at the 3 key rewards and 2 important warning signs .
Looking for more investment ideas beyond Teladoc Health?
If Teladoc Health has you rethinking your watchlist, do not stop here. Use the Simply Wall Street Screener to uncover fresh opportunities that could fit your goals.
-
Target stronger income potential by scanning companies with robust yields using the 8 dividend fortresses .
-
Spot opportunities trading below their estimated worth by reviewing the 56 high quality undervalued stocks .
-
Prioritise resilience by checking companies highlighted in the 89 resilient stocks with low risk scores .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TDOC .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
